Previous research has also found a role for SIRT3 in the context of cardiac hypertrophy, as transgenic mice overexpressing SIRT3 were reportedly protected from the development of angiotensin II‐induced cardiac hypertrophy (Sundaresan et al., 2009). The gene discussed is AGT; the disease is cardiac hypertrophy.